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Outbreak of 
Pertussis, Kabul, 
Afghanistan 
To  the Editor: Infectious dis-
eases are the main cause of illness for 
armed forces in conﬂ  ict (1), resulting 
in decreases in operational efﬁ  ciency. 
The International Security Assistance 
Force (ISAF) in Afghanistan is a mul-
tinational force operating under the 
auspices of the North Atlantic Treaty 
Organization (NATO). As part of 
ISAF, French troops operate in Kabul 
and its surroundings, within a 70-km 
radius. French medical facilities con-
sist of a French ﬁ  eld hospital and a 
primary care center. The facilities sup-
port 4,000 soldiers, 1,048 of whom are 
French.
Troop disease, including acute re-
spiratory disease (ARD), is routinely 
monitored through French Army and 
NATO surveillance systems. We re-
port an outbreak of ARD in the multi-
national force in which pertussis cases 
were identiﬁ   ed by using laboratory 
tests and epidemiologic criteria.
In November 2006, a signiﬁ  cant 
increase of ARD was detected in sol-
diers of different nationalities (Figure), 
with a 10-fold increase among French 
troops at week 51. Patients with per-
sistent cough or dyspnea were referred 
to the ﬁ  eld hospital, in a nonrandom-
ized manner, and those with a 2-week 
history of cough underwent serologic 
tests. Samples were sent to France and 
were analyzed at Hôpital Saint Anne, 
Toulon, France. Immunoglobulin (Ig) 
G antibodies to Bordetella pertussis 
antigens (pertussis toxin, ﬁ  lamentous 
hemagglutinin, and adenylcyclase) 
were determined by a Western blot 
assay (MarDx Diagnostics, Carlsbad, 
CA, USA). Recent infection was diag-
nosed by ﬁ  nding high levels of anti-
bodies to pertussis toxin compared to 
results for standardized positive and 
negative samples, in concurrence with 
the fact that no soldier had been vacci-
nated against pertussis after childhood. 
IgG and IgA antibodies to Chlamydia 
pneumoniae were determined by a 
semiquantitative method that assessed 
samples’ absorbance value in optical 
density (SeroCP Quant IgG and Quant 
IgA, Savyon Diangostics, Ashdod, Is-
rael). Recent infection to Mycoplasma 
pneumoniae was assessed by detecting 
IgM antibodies with a speciﬁ  c enzyme 
immunoassay (Platelia Mycoplasma 
pneumoniae, Biorad, Hercules, CA, 
USA) and by using a semiquantitative 
method to detect IgM and IgG anti-
bodies with patented gelatin particles 
sensitized with cell membrane com-
ponents of M. pneumoniae (Serodia 
Myco II, Fujirebio, Malvern, PA, 
USA). Coxiella burnetii infection was 
assessed by indirect immunoﬂ  uores-
cence assay (Coxiella burnetii Spot IF, 
bioMérieux, Marcy l’Etoile, France).
Statistical analysis was performed 
with Epi Info v3.4 software package 
(Centers for Disease Control [CDC], 
Atlanta, GA, USA). Quantitative vari-
ables were compared by using the 
Kruskall-Wallis test.
From the third week of Decem-
ber 2006 until the third week of Janu-
ary 2007, 209 French soldiers sought 
treatment at the French medical facili-
ties for stereotyped acute febrile re-
spiratory infection, which represents 
a cumulative attack rate of 20% on 
clinical grounds. Thirty-nine French 
soldiers and 10 non-French soldiers 
or local civilian workers were then re-
ferred to the ﬁ  eld hospital. All patients 
had a 24-h history of fever >38.5°C 
and nonspeciﬁ  c ear, nose, and throat 
symptoms, mainly a sore throat. Cough 
was unremarkable, without whoops. 
Fourteen of the 49 patients were hos-
pitalized for severe dyspnea. Median 
age was the same for inpatients (26 
[range 20–57] years) and outpatients 
(36 [range 21–53] years, p = 0.15).
Twenty-seven blood samples were 
taken, 24 from French troops, 2 from 
British troops, and 1 from Polish pa-
tients. Six patients, including 3 French 
soldiers, had recent pertussis. No dif-
ference in age was found between 
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patients with pertussis and those with 
non–pertussis ARD (36 [range 27–51] 
versus 33 [range 20–63] years; p = 
0.39). No pertussis patient had been 
vaccinated against the illness since 
childhood.
One patient had evidence of re-
cent infection with M. pneumoniae, 
and another with C. pneumoniae. No 
recent infection involved C. burnetii. 
All patients with ARD had a favorable 
outcome.
This outbreak of ARD among 
troops in Afghanistan highlights the 
importance of nontraumatic illness in 
wartime when military ﬁ  eld conditions 
enhance exposure to, and incidence of, 
endemic diseases. Although our study 
did not include systematic laboratory 
conﬁ  rmation for all cases of ARD in 
soldiers due to ﬁ  eld conditions, this 
outbreak was mainly due to pertussis: 
most cases were deﬁ  ned by a cough 
lasting >2 wk, took place in an out-
break setting, and were (for 6 patients) 
conﬁ   rmed by laboratory tests. CDC 
requirements were followed to ascer-
tain conﬁ  rmed cases (2). This outbreak 
also involved British troops; after the 2 
cases we described, 2 additional sero-
logically conﬁ  rmed cases and 1 prob-
able conﬁ  rmed case were discovered 
among symptomatic British returnees 
(3). Pertussis, which remains endemic 
in developing countries (4), was re-
ported in northeastern Afghanistan in 
2002 (5), nor was it ever biologically 
ascertained nor reported in Kabul.
This outbreak elicits 3 main ques-
tions. First, how can ARD transmission 
be stopped under ﬁ  eld conditions? Be-
sides prophylactic antibiotherapy, iso-
lation of suspected case-patients is not 
achievable because of limited number 
of beds in medical facilities and high-
person density in barracks and din-
ing halls. To minimize transmission, 
patients and caregivers should wear 
masks. 
Second, what prophylactic antibi-
otherapy should be given? We recom-
mend a 3-day regimen of azithromycin 
because it is as efﬁ  cient as erythro-
mycin in preventing spread pertussis 
(6), targets most intracellular bacteria 
involved in ARD, and offers the best 
compliance (7). 
Finally, should soldiers be vac-
cinated against pertussis for overseas 
campaigns? In France, no booster vac-
cination is given after 13 years of age 
(8). Because acellular vaccines do not 
ensure immunity for >6 years (5), no 
French soldier has immunity to per-
tussis. We therefore advocate booster 
vaccination before overseas cam-
paigns. Pertussis vaccination is widely 
available in combination with vacci-
nation against, at minimum, diphthe-
ria and tetanus, but these combination 
vaccines can only be performed once 
in an adult’s life and only 2 years after 
previous vaccination against diphthe-
ria or tetanus. Monovalent vaccines 
against pertussis must be made more 
widely available for multinational 
troops in ﬁ  eld conditions.
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Anthropogenic 
Inﬂ  uence on 
Prevalence of 
2 Amphibian 
Pathogens
To the Editor: Although the re-
lationship between the emergence of 
zoonotic diseases and human inﬂ  u-
enced landscapes is accepted (1–3), 
the relationship between human-in-
ﬂ  uenced landscapes and wildlife dis-
ease is less so. Evidence does support 
correlations between human activities 
and environmental conditions affect-
ing wildlife disease emergence (2,3). 
These studies assume relationships 
between component(s) of human hab-
itat modiﬁ  cation and the virulence of 
disease, and derive estimates of viru-
lence from counts of the visibly dis-
eased or those that have seroconverted 
(3). This explains only part of the host 
and pathogen dynamic; it seems rea-
sonable to extend the relationship to 
include prevalence of infection. Data 
supporting this extension are lacking. 
Here we present data from a study 
examining the correlations between 
human inﬂ   uences on habitat and 
prevalence of 2 amphibian pathogens 
(Batrachochytrium dendrobatidis and 
ranavirus FV3) in populations of Rana 
clamitans in central and northeastern 
Ontario, Canada.
We sampled an average of 25 ani-
mals (standard deviation ± 6.16) from 
11 populations during summer 2005. 
We washed equipment in bleach and 
air-dried equipment between visits 
and sites. All animals were kept in-
dividually to avoid cross-contamina-
tion, euthanized with MS22, and as-
sessed for infection using molecular 
diagnostics. We tested for ranavirus 
infection of livers by amplifying the 
major capsid protein using standard 
PCR (4). We tested for infection with 
B. dendrobatidis by using a quantita-
tive real-time PCR (5). Prevalence for 
each pathogen was estimated as the 
proportion of animals testing positive 
at a pond.
Site coordinates were determined 
by using global positioning satellite 
(GPS), and 4 quantitative measures of 
human habitat modiﬁ  cation were also 
assessed. GPS coordinates were used 
to map sites and to measure distance 
to the nearest road, industrial activity 
(agriculture, mine, paper mill), and 
human habitation; all measurements 
were in meters. We further assigned 
a qualitative measure of human inﬂ  u-
ence on each breeding pond by as-
signing ponds to each of the following 
categories: 1) human presence without 
human habitat modiﬁ  cation or exten-
sive disturbance; 2) recreational ac-
tivities (ﬁ  shing, boating); 3) property 
development (housing or commercial 
buildings); 4) agricultural activity; 
and 5) industrial activity. Each of the 
5 categories was assigned a 0/1 score; 
scores for each pond were summed 
1–5 (by deﬁ   nition no site scored 0 
due to sampling strategy) to derive 
the ﬁ  nal measure of human inﬂ  uence. 
We modeled the relationship between 
prevalence and human habitat modiﬁ  -
cation or inﬂ  uence using general linear 
models (GLM) with prevalence as the 
dependent variable and with all human 
inﬂ  uence variables log-transformed to 
meet assumptions of normality. A type 
III model structure was used to ac-
count for the inﬂ  uence of all explana-
tory variables in each analysis. 
Eight ponds exhibited signs of FV3 
infection (range 0%–63% prevalence); 
6 ponds contained frogs infected with 
the amphibian chytrid (range 0%–36% 
prevalence). GLM did not show any 
relationship between the prevalence of 
chytrid infection and all of our explana-
tory variables (Table). In contrast, 3 of 
our explanatory variables had a signiﬁ  -
cant inﬂ  uence of ranavirus prevalence. 
Distance to industrial activity (p<0.05), 
to human habitation (p<0.05), and de-
gree of human inﬂ  uence (p<0.01) all 
had a signiﬁ  cant effect on the depen-
dent variable (Table).
The disparity between results for 
the 2 pathogens generates several pos-
sible hypotheses. First, proximity to 
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Table. General linear models for the relationships of amphibian emerging infectious disease prevalence and anthropogenic variables
Ranavirus Batrachochytrium dendrobatidis
Data point 
Degrees of 
freedom Mean squares  F value  Mean squares  F value 
Intercept 1 0.06 8.47 (p<0.05)  0.05 4.61 (p<0.1) 
Human disturbance  1 0.24 35.35 (p<0.01)  0.0009 0.08
Distance to road  1 0.03 4.11 (p<0.1)  0.03 2.82
Distance to industry  1 0.06 8.82 (p<0.05)  0.07 5.89 (p<0.1) 
Distance to housing  1 0.06 8.08 (p<0.05)  0.06 4.87 (p<0.1) 
Error 5 0.01 0.01